The results revealed that SUMOylation and several common tumor-related pathways, such as cell cycle, neurotrophin signaling pathway, pathways in cancer, base excision repair, MAPK, VEGF, and P53 signaling pathway, were significantly enriched in the high-risk patients (Supplementary Fig. 2). The gene discussed is TP53; the disease is neoplasm.